COVID-19 in vaccinated versus unvaccinated hematologic malignancy patients

© 2022 Wiley Periodicals LLC..

The effect of vaccination on severity of subsequent COVID-19 in patients with hematologic malignancies (HMs) is unknown. In this single-center retrospective cohort study, we found no difference in severity of COVID-19 disease in vaccinated (n = 16) versus unvaccinated (n = 54) HM patients using an adjusted multiple logistic regression model. Recent anti-B-cell therapy was associated with more severe illness.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:24

Enthalten in:

Transplant infectious disease : an official journal of the Transplantation Society - 24(2022), 6 vom: 04. Dez., Seite e13835

Sprache:

Englisch

Beteiligte Personen:

DeVoe, Catherine [VerfasserIn]
Pandey, Shraddha [VerfasserIn]
Shariff, Dayana [VerfasserIn]
Arora, Shagun [VerfasserIn]
Henrich, Timothy J [VerfasserIn]
Yokoe, Deborah S [VerfasserIn]
Langelier, Charles R [VerfasserIn]
Servellita, Venice [VerfasserIn]
Chiu, Charles [VerfasserIn]
Miller, Steve [VerfasserIn]
Babik, Jennifer M [VerfasserIn]
Chin-Hong, Peter [VerfasserIn]
Fung, Monica [VerfasserIn]

Links:

Volltext

Themen:

Breakthrough infection
COVID-19
Hematologic malignancy
Journal Article

Anmerkungen:

Date Completed 23.12.2022

Date Revised 03.01.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1111/tid.13835

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM33955696X